It was shown to induce cell cycle arrest and apoptosis by downregulating the expression of wild-type and mutated EGFR and inhibiting EGFR downstream effectors (AKT and ERK1/2) in lung cancer cells in vitro [15]. Here, EGFR is linked to lung carcinoma.